Research on the placebo effect contains important elements that can be harnessed to improve clinical care. This paper proposes a new term, “Belief Activation,” to describe the deliberate use of placebo effect tools by both patients and clinicians to catalyze healing. Belief Activation includes, but is not limited to, maximizing patient and practitioner expectations, classical and social conditioning, spirituality and prayer/intention, therapeutic relationship, healing environments, and minimizing the nocebo effect. This paper demonstrates ways in which Belief Activation is a form of evidence-based medicine and seeks to translate knowledge from placebo research into medical practice.
Get full access to this article
View all access options for this article.
References
1.
HashishI, HaiHK, HarveyW, et al.Reduction of postoperative pain and swelling by ultrasound treatment: A placebo effect. Pain, 1988; 33:303–311.
2.
MerzM, SeiberlingM, HöxterG, et al.Elevation of liver enzymes in multiple dose trials during placebo treatment: Are they predictable?. J Clin Pharmacol, 1997; 37:791–798.
3.
ButlerC, SteptoeA. Placebo responses: An experimental study of psychophysiological processes in asthmatic volunteers. Br J Clin Psychol, 1986; 25:173–183.
4.
KemenyME, RosenwasserLJ, PanettieriRA, et al.Placebo response in asthma: A robust and objective phenomenon. J Allergy Clin Immunol, 2007; 119:1375–1381.
5.
GiangDW, GoodmanAD, SchifferRB, et al.Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci, 1996; 8:194–201.
6.
SievenpiperJL, EzataghaA, DascaluA, et al.When a placebo is not a ‘placebo’: A placebo effect on postprandial glycaemia. Br J Clin Pharmacol, 2007; 64:546–549.
7.
VolkowND, WangGJ, MaY, et al.Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci, 2003; 23:11461–11468.
8.
KaasinenV, AaltoS, NågrenK, et al.Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci, 2004; 19:2352–2356.
9.
van der MolenGM, van den HoutMA. Expectancy effects on respiration during lactate infusion. Psychosom Med, 1988; 50:439–443.
10.
BenedettiF, RaineroI, PolloA. New insights into placebo analgesia. Curr Opin Anaesthesiol, 2003; 16:515–519.
11.
VaseL, VollertJ, FinnerupNB, et al.Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: A meta-analysis of the individual data from nine industrially sponsored trials. Pain, 2015; 156:1795–1802.
12.
RibeiroSC, TandonR, GrunhausL. The DST as a predictor of outcome in depression: A meta-analysis. Am J Psychiatry, 1993; 150:1618–1629.
13.
MeissnerK, KohlsN, CollocaL. Introduction to placebo effects in medicine: Mechanisms and clinical implications. Philos Trans R Soc Lond B Biol Sci, 2011; 366:1783–1789.
14.
BasuP, DuttaS, BegumR, et al.Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: A phase II randomized controlled study. Asian Pac J Cancer Prev, 2013; 14:5753–5759.
15.
ParkH, QinR, SmithTJ, et al.North Central Cancer Treatment Group N10C2 (Alliance): A double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause, 2015; 22:627–632.
16.
de la CruzM, HuiD, ParsonsHA, et al.Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer, 2010; 116:766–774.
17.
KaptchukTJ, FriedlanderE, KelleyJM, et al.Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS One, 2010; 5:e15591.
18.
DohertyM, DieppeP. The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage, 2009; 17:1255–1262.
19.
BishopFL, HowickJ, HeneghanC, et al.Placebo use in the UK: A qualitative study exploring GPs' views on placebo effects in clinical practice. Fam Pract, 2014; 31:357–363.
20.
Kam-HansenS, JakubowskiM, KelleyJM, et al.Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med, 2014; 6:218ra5.
21.
CamillleriM, NorthcuttAR, KongS, et al.Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomized, placebo controlled trial. Lancet, 2000; 355:1034–1040.
22.
KirschI.The emperor's new drugs: Medication and placebo in the treatment of depression. Handb Exp Pharmacol, 2014; 225:291–303.
23.
PadulaAM, PressmanAR, VittinghoffE, et al.Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med, 2012; 125:804–810.
24.
MoseleyJB, O'MalleyK, PetersenNJ, et al.A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med, 2002; 347:81–88.
25.
CobbLA, ThomasGI, DillardDH. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med, 1959; 260:1115–1118.
26.
MeissnerK, FässlerM, RückerG, et al.Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis. JAMA Intern Med, 2013; 173:1941–1951.
27.
HróbjartssonA, GøtzschePC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev, 2010:CD003974.
28.
HullSC, CollocaL, AvinsA, et al.Patients' attitudes about the use of placebo treatments: Telephone survey. BMJ, 2013; 347:f3757.
29.
OrtizR, Chandros HullS, CollocaL. Patient attitudes about the clinical use of placebo: Qualitative perspectives from a telephone survey. BMJ Open, 2016; 6:e011012.
30.
MondlochMV, ColeDC, FrankJW. Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes. CMAJ, 2001; 165:174–179.
31.
UhlenhuthEH, RickelsK, FisherS, et al.Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia, 1966; 9:392–418.
32.
GryllSL, KatahnM. Situational factors contributing to the placebos effect. Psychopharmacology (Berl), 1978; 57:253–261.
33.
ThomasKB.General practice consultations:is there any point in being positive?. Br Med J, 1987; 294:1200–1202.
34.
Di BlasiZ, HarknessE, ErnstE, et al.Influence of context effects on health outcomes: A systematic review. Lancet, 2001; 357:757–762.
35.
GeersAL, WeilandPE, KosbabK, et al.Goal activation, expectations, and the placebo effect. J Pers Soc Psychol, 2005; 89:143–159.
36.
VitsS, CeskoE, EnckP, HillenU, SchadendorfD, SchedlowskiM. Behavioral conditioning as the mediator of placebo responses in the immune system. Philos Trans R Soc Lond B Biol Sci, 2011; 366:1799–1807.
37.
BarryS.Oken. Placebo effects: Clinical aspects and neurobiology. Brain, 2008; 131:2812–2823.
38.
CollocaL, LopianoL, LanotteM, et al.Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol, 2004; 3:679–684.
39.
AderR, MercurioMG, WaltonJ, et al.Conditioned pharmacotherapeutic effects: A preliminary study. Psychosom Med, 2010; 72:192–197.
40.
SandlerAD, GlesneCE, BodfishJW. Conditioned placebo dose reduction: A new treatment in attention-deficit hyperactivity disorder?. J Dev Behav Pediatr, 2010; 31:369–375.
41.
OlnessK, AderR. Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediatr, 1992; 13:124–125.
42.
RussellB.Why Men Fight: A Method of Abolishing the International Duel. New York: The Century Co., 1917.
43.
CollocaL, BenedettiF. Placebo analgesia induced by social observational learning. Pain, 2009; 144:28–34.
44.
EgorovaN, ParkJ, OrrSP, et al.Not seeing or feeling is still believing: Conscious and non-conscious pain modulation after direct and observational learning. Sci Rep, 2015; 5:16809.
45.
SütterlinS, EgnerLE, LugoRG, et al.Beyond expectation: A case for nonpersonal contextual factors in a more comprehensive approach to the placebo effect and the contribution of environmental psychology. Psychol Res Behav Manag, 2015; 8:259–262.
46.
RutherfordBR, RooseSP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry, 2013; 170:723–733.
47.
BratmanGN, HamiltonJP, HahnKS, et al.Nature experience reduces rumination and subgenual prefrontal cortex activation. Proc Natl Acad Sci U S A, 2015; 112:8567–8572.
48.
BeilK, HanesD, ZwickeyH. Environmental influence on holistic health measures. Explore, 2014; 10:115–117.
49.
HagermanI, RasmanisG, BlomkvistV, UlrichR, EriksenCA, TheorellT. Influence of intensive coronary care acoustics on the quality of care and physiological state of patients. Int J Cardiol, 2005; 98:267–270.
50.
DevlinAS, ArneillAB. Health care environments and patient outcomes a review of the literature. Environ Behav, 2003; 35:665–694.
51.
KumarS.Burnout and doctors: Prevalence, prevention and intervention. Healthcare (Basel), 2016; 4. pii: E37; DOI: 10.3390/healthcare4030037.
PamelaGR.An emerging paradigm for the investigation of spirituality in nursing. Res Nurs Health, 1992; 15:349–357.
54.
KohlsN, SauerS, OffenbächerM, GiordanoJ. Spirituality: An overlooked predictor of placebo effects?. Philos Trans R Soc Lond B Biol Sci, 2011; 366:1838–1848.
55.
HylandME, GeraghtyAW, JoyOE, TurnerSI. Spirituality predicts outcome independently of expectancy following flower essence self-treatment. J Psychosom Res, 2006; 60:53–58.
56.
HylandM, WhalleyB, GeraghtyA. Dispositional predictors of placebo responding: A motivational interpretation of flower essence and gratitude therapy. J Psychosom Res, 2007; 62:331–340.
57.
SeemanTE, DubinLF, SeemanM. Religiosity/spirituality and health. A critical review of the evidence for biological pathways. Am Psychol, 2003; 58:53–63.
58.
KelleyJ, GordonK, SchapiraL, et al.The Influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials. PLoS One, 2014; 9:e94207.
59.
StewartMA.Effective physician-patient communication and health outcomes: A review. CMAJ, 1995; 152:1423–1433.
60.
VarelmannD, PancaroC, CappielloEC, et al.Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg, 2010; 110:868–870.
61.
SoxHCJr., MarguliesI, SoxCH.Psychologically mediated effects of diagnostic tests. Ann Intern Med, 1981; 95:680–685.
62.
BergmannJ-F, ChassanyO, Gandiol, et al.A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal, 1994; 29:41–47.
63.
EgbertLD, BattitGE, WelchCE, et al.Reduction of postoperative pain by encouragement and instruction of patients. A study of doctor–patient rapport. N Engl J Med, 1964; 270:825–827.
64.
McKayKM, ImelZE, WampoldBE. Psychiatrist effects in the psychopharmacological treatment of depression. J Affect Disord, 2006; 92:287–290.
65.
HojatM, LouisDZ, MarkhamFW, et al.Physicians' empathy and clinical outcomes for diabetic patients. Acad Med, 2011; 86:359–364.
66.
DosseyL.Telecebo: Beyond Placebo to an Expanded Concept of Healing. Explore (NY), 2016; 12:1–12.
67.
RoeCA, SonnexC, RoxburghE. Two meta-analyses of distant healing studies. J Parapsychol, 2012; 76:223–224.
68.
HodgeDR.A systematic review of the empirical literature on intercessory prayer. Res Soc Work Pract, 2007; 17:174–187.
69.
SchmidtS, SchneiderR, UttsJ, et al.Distant intentionality and the feeling of being stared at—Two meta-analyses. Br J Psychol, 2004; 95:235–247.
70.
AstinJE, HarknessE, ErnstE. The efficacy of “distant healing”: A systematic review of randomized trials. Ann Intern Med, 2000; 132:903–910.
71.
AbbotNC.Healing as a therapyfor human disease: A systematic review. J Altern Complement Med, 2000; 6:159–169.
72.
SchmidtS.Can we help by good intentions? A meta-analysis of experiments and distant intention effects. J Altern Complement Med, 2012; 18:529–533.
73.
KuwadaG.Distant intentionality healing and its effects on post-operative pain and narcotic usage after foot and ankle surgery. Foot Ankle Online J, 2013; 6:1.
74.
ShiahYJ, RadinD. Metaphysics of the tea ceremony: A randomized trial investigating the roles of intention and belief on mood while drinking tea. Explore (NY), 2013; 9:355–360.
75.
AmanzioM, CorazziniLL, VaseL, et al.A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain, 2009; 146:261–269.
76.
ColagiuriB, DhillonH, ButowPN, et al.Does assessing patients' expectancies about chemotherapy side effects influence their occurrence?. J Pain Symptom Manage, 2013; 46:275–281.
77.
DanielsAM.Headache, lumbar pucture, and expectation. Lancet, 1981; 1:1003.
78.
LambGC, GreenSS, HeronJ. Can physicians warn patients of potential side effects without fear of causing those side effects?. Arch Intern Med, 1994; 154:2753–2756.
79.
HeisigSR, Shedden-MoraMC, HidalgoP, et al.Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study. Health Psychol, 2015; 34:1033–1037.
80.
TapperEB.Doctors on display: The evolution of television's doctors. Proc (Bayl Univ Med Cent), 2010; 23:393–399.
